DXP-106 in Solid Tumor Patients.

Clinical trial NCT07532018 · RECRUITING

Trial details

NCT number: NCT07532018
Sponsor: Singlomics Biopharmaceuticals Zhuhai Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Cancer

Start date: 2026-03-23
Primary completion: 2028-02-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.